Impact of Pharmacist–Psychiatrist Collaborative Patient Education on Medication Adherence and Quality of Life (QOL) of Bipolar Affective Disorder (BPAD) Patients

Mishra, Ambed; Gudi, Sai Krishna; Alla, Sravani; Kurian, Tony D; Kurian, Justin; Ramesh, Madhan; Kishor, M

doi:10.3389/fphar.2017.00722

Cited by 19 publications

(11 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These interventions were delivered by the pharmacist individually or as a group and focused on medication and disease state information and lifestyle modification recommendations, discussing the importance of medication adherence, and providing advice on how to manage medication side effects. Educational and counselling materials were developed based on published information such as consumer information leaflets (Mishra et al, 2017a(Mishra et al, , 2017b or information derived from the US pharmacopoeia (Kaukab et al, 2015) or guidelines from the American Society of Hospital Pharmacists (Greco, 1994).…”

Section: Pharmacist-led Intervention Componentsmentioning

confidence: 99%

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

El-Den

Stewart

et al. 2021

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Objective: People living with severe and persistent mental illness experience poorer physical health, often due to medication and preventable lifestyle factors, and exacerbated by barriers to accessing healthcare services. Pharmacists are well-positioned to improve the physical and mental health of this population. However, little is known about pharmacists’ current practices when providing services to this population nor the impact of pharmacist-led interventions on consumer health outcomes. We undertook a systematic review to identify, describe and assess the effectiveness of pharmacist-led interventions for supporting people living with severe and persistent mental illness and the impact on consumer outcomes. Methods: MEDLINE, Embase, PsycINFO, CINAHL, Web of Science, Scopus, Cochrane Library, International Pharmaceutical Abstracts and ProQuest Dissertations and Theses were searched between January 1990 and April 2020. Full-text studies exploring pharmacist-led interventions in any setting for people living with severe and persistent mental illness were included. A risk of bias assessment was conducted. Results: A total of 37 studies were included. More than half of the pharmacist interventions were multifaceted. The most common components of pharmacist-led interventions included education and/or patient counselling, providing recommendations to healthcare professionals and conducting medication reviews. Multifaceted interventions demonstrated improvements in clinical outcomes, whereas single interventions focused mostly on consumer-reported outcomes. The methodological quality of included studies was moderate-to-high risk of bias and there was considerable heterogeneity in the study design, interventions described, and outcomes reported. Conclusion: There is evidence that pharmacist-led interventions improve consumer-reported and clinical outcomes for people living with severe and persistent mental illness. Pharmacists are capable and have a role in supporting people living with severe and persistent mental illness, either individually or as interprofessional collaborators with other healthcare professionals. Future research should attempt to better understand which particular intervention components have the greatest impact and also evaluate the implementation and long-term sustainability of such interventions.

show abstract

Section: Pharmacist-led Intervention Componentsmentioning

confidence: 99%

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

El-Den

Stewart

et al. 2021

Aust N Z J Psychiatry

View full text Add to dashboard Cite

show abstract

“…Pharmacists, as part of an interdisciplinary team, can have a number of clinical responsibilities and positive impact. These responsibilities may include providing medication information and recommendations to providers, [6][7][8] educating patients about psychotropic medications, 7,9 or providing direct patient care through office or telephone visits. 7,8,10,11 Outpatient psychiatric pharmacist services have made a significant impact on patient care.…”

Section: Introductionmentioning

confidence: 99%

Assessment of the current practice of psychiatric pharmacists in the United States

Silvia

Lee

Bostwick

et al. 2020

Mental Health Clinician

View full text Add to dashboard Cite

Introduction A comprehensive review of psychiatric pharmacy practice has never been performed in the United States. As psychiatric pharmacists become more involved in mental illness treatment, determining the current state of practice is important to help advance the specialty. The Professional Affairs Committee of the College of Psychiatric and Neurologic Pharmacists (CPNP) was charged with performing this review to define current psychiatric pharmacy practice. Methods An electronic survey was sent to all pharmacist members of CPNP and all nonmember Board Certified Psychiatric Pharmacists (BCPPs) in the United States in late summer 2019. The survey consisted of 36 questions across multiple domains to obtain information about respondents' education and training background, practice setting and type, and information about prescriptive authority and other areas. An initial e-mail invitation was sent along with 2 reminder e-mails over the subsequent 2 weeks. Results A total of 334 of 1015 pharmacists completed the survey (32.9%). Responders completed a postgraduate residency 77.8% of the time, and 88.3% were BCPP. Practice settings were split evenly between inpatient and outpatient practices or a combination of the 2. Among respondents, 46.5% reported having prescriptive authority as part of their practice, and 41.3% reported treating nonpsychiatric as well as psychiatric illnesses. Prescriptive authority was more likely in outpatient practices and in those treating nonpsychiatric illnesses. Discussion The current practice of psychiatric pharmacy is incredibly varied in terms of practice setting, activities performed, and services provided. Further exploration is needed to help determine the optimal role of psychiatric pharmacists.

show abstract

“…These centers were established to provide psychosocial support services for patients with severe mental illness such as bipolar disorder, schizophrenia, and unspecified schizophrenia spectrum and other psychotic disorder (USS&OPD). Treatment adherence, quality of life and social cognitive functions are impaired in schizophrenia and bipolar disorder (6,7). Therefore, an integrated and multidimensional approach should be used to reduce non-adherence to treatment and increase the quality of life of patients.…”

Section: Introductionmentioning

confidence: 99%

“…After patients are admitted to CMHC, psychotherapy is given to them, and patients along with their relatives are provided with psychoeducation and skill training by teachers assigned by public education centers, taking their needs and capabilities into consideration within the scope of orientation studies. The studies about participation frequencies were mostly on psycho-education frequency, antistigmatization and public awareness (7,9,10). A study found that psychosocial skills training once in two weeks was provided significant contribution in symptoms and functioning in nineteen schizophrenia patients (11).…”

Section: Introductionmentioning

confidence: 99%

The effects of the frequency of participation to the community mental health center on insight, treatment adherence and functionality (eng)

Şahin¹,

Elboğa²,

Altındağ³

2020

J Clin Psy

View full text Add to dashboard Cite

The effects of the frequency of participation to the community mental health center on insight, treatment adherence and functionality Toplum ruh sağlığı merkezine katılım sıklığının içgörü, tedavi uyumu ve işlevselliğe etkisi SUMMARY Objective: Community Mental Health Centers (CMHC) were established to provide psychosocial support services for patients with severe mental disorders such as bipolar disorder, schizophrenia, unspecified schizophrenia spectrum and other psychotic disorder. The aim of our study was to determine the effects of participation frequency in a CMHC on insight, treatment adherence and functionality in severe mental disorders. Method: 362 patients diagnosed with bipolar disorder and psychosis according to the DSM-5 criteria and treated in CMHC were included in this retrospective study. The participation frequency of patients benefited from CMHC services for a year was retrospectively screened. The patients had been evaluated with Clinical Global Impression Scale (CGI), Medication Adherence Rating Scale (MARS), Global Assessment of Functioning (GAF), and Schedule for Assessing the Three Components of Insight (SATCI), and Functional Remission of General Schizophrenia Scale (FROGS). Patients were divided into two groups as bipolar disorder and psychosis (schizophrenia, schizoaffective and USS&OPD). Results: The patients had been participated in CMHC services in 6 different frequency groups: 68 (18.8%) once in six months, 62 (17.1%) once in three months, 68 (18.8%) once in two months, 98 (27.1%) once/twice a month, 34 (9.4%) once/twice a week, 32 (8.8%) three/four times a week, respectively. There were significant differences between GAF, CGI, SATCI, MARS, FROGS scores in terms of participation frequencies of psychosis group and there were significant differences between GAF, CGI, MARS scores in terms of participation frequencies of bipolar disorder group at the end of one year. Discussion: In general, as the participation frequency increased, insight, treatment adherence and functionality increased. In addition to individual factors, our results will also contribute to determine the frequency of participation in CMHC.

show abstract

Impact of Pharmacist–Psychiatrist Collaborative Patient Education on Medication Adherence and Quality of Life (QOL) of Bipolar Affective Disorder (BPAD) Patients

Cited by 19 publications

References 16 publications

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

Assessment of the current practice of psychiatric pharmacists in the United States

The effects of the frequency of participation to the community mental health center on insight, treatment adherence and functionality (eng)

Contact Info

Product

Resources

About